Publicacións en colaboración con investigadores/as de Monash University (12)

2024

  1. Correction: Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta‑analysis (Reviews in Endocrine and Metabolic Disorders, (2024), 25, 2, (447-448), 10.1007/s11154-023-09837-x)

    Reviews in Endocrine and Metabolic Disorders

2023

  1. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  2. Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c

    Nature Medicine, Vol. 29, Núm. 11, pp. 2885-2901

  3. Vitamin D status and supplementation before and after Bariatric Surgery: Recommendations based on a systematic review and meta-analysis

    Reviews in Endocrine and Metabolic Disorders, Vol. 24, Núm. 6, pp. 1011-1029

2022

  1. Efficacy of empagliflozin in heart failure with preserved versus mid-range ejection fraction: a pre-specified analysis of EMPEROR-Preserved

    Nature Medicine, Vol. 28, Núm. 12, pp. 2512-2520

2021

  1. Empagliflozin in heart failure with a preserved ejection fraction

    New England Journal of Medicine, Vol. 385, Núm. 16, pp. 1451-1461

2020

  1. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

    European Journal of Heart Failure, Vol. 22, Núm. 12, pp. 2383-2392

2019

  1. Standards of practice in acute ischemic stroke intervention: International recommendations

    Interventional Neuroradiology, Vol. 25, Núm. 1, pp. 31-37

2018

  1. Standards of practice in acute ischemic stroke intervention: International recommendations

    Journal of NeuroInterventional Surgery, Vol. 10, Núm. 11, pp. 1121-1126

  2. Standards of practice in acute ischemic stroke intervention: International recommendations

    American Journal of Neuroradiology, Vol. 39, Núm. 11, pp. E112-E117

2016

  1. Oxaliplatin and 5-FU/folinic acid (modified FOLFOX6) with or without aflibercept in first-line treatment of patients with metastatic colorectal cancer: The AFFIRM study

    Annals of Oncology, Vol. 27, Núm. 7, pp. 1273-1279

2015

  1. Ghrelin

    Molecular Metabolism, Vol. 4, Núm. 6, pp. 437-460